Robert Hofmeister
Chief Scientific Officer, TCR2 THERAPEUTICS INC.
Companies
- ZIOPHARM OncologyBoard member Apr 19, 2023 to Jun 10, 20241
- TCR2 THERAPEUTICS INC.Chief Scientific Officer Feb 13, 2019 to Dec 10, 20212
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- TCR2 THERAPEUTICS INC.45,850 shares3Dec 10, 2021
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZIOPHARM Oncology, Board member
- 2
- 3